SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9336353
Source:
http://linkedlifedata.com/resource/pubmed/id/9336353
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0008976
,
umls-concept:C0242802
,
umls-concept:C1328050
,
umls-concept:C2347946
pubmed:issue
10
pubmed:dateCreated
1997-10-30
pubmed:abstractText
To evaluate the impact of the selection criteria that are used in current high-dose consolidation chemotherapy (HDCT) trials on the outcome of high-risk breast cancer patients treated with conventional adjuvant chemotherapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9336353-9336351
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9336353-9469383
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0732-183X
pubmed:author
pubmed-author:CalzasJJ
,
pubmed-author:ColomerRR
,
pubmed-author:Cortés-FunesHH
,
pubmed-author:GómezHH
,
pubmed-author:García-CarboneroRR
,
pubmed-author:GuernéJ MJM
,
pubmed-author:HidalgoMM
,
pubmed-author:HittRR
,
pubmed-author:HornedoJJ
,
pubmed-author:Paz-AresLL
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3178-84
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9336353-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:9336353-Breast Neoplasms
,
pubmed-meshheading:9336353-Chemotherapy, Adjuvant
,
pubmed-meshheading:9336353-Clinical Trials as Topic
,
pubmed-meshheading:9336353-Disease-Free Survival
,
pubmed-meshheading:9336353-Female
,
pubmed-meshheading:9336353-Follow-Up Studies
,
pubmed-meshheading:9336353-Humans
,
pubmed-meshheading:9336353-Lymphatic Metastasis
,
pubmed-meshheading:9336353-Middle Aged
,
pubmed-meshheading:9336353-Multivariate Analysis
,
pubmed-meshheading:9336353-Patient Selection
,
pubmed-meshheading:9336353-Prognosis
,
pubmed-meshheading:9336353-Risk Factors
,
pubmed-meshheading:9336353-Selection Bias
,
pubmed-meshheading:9336353-Survival Rate
pubmed:year
1997
pubmed:articleTitle
Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.
pubmed:affiliation
Division of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain.
pubmed:publicationType
Journal Article